It's official, our French "CEO in training" did absolutely nothing during his first days in office. The global annoucements yesterday are status quo of the same old problems this company has faced since it ran out of luck after the loss of expiry with Actos.
Takeda has more than DOUBLED in size in the last 4 years and has nothing to show on the bottom line for all this growth. The company desperately needs strong leadership at the top and all we got so far from the Frenchie is a good signal that he has no backbone to make significant and painful changes that this company so desperately needs.
There is no "one Takeda", the corporation operates as 8 or 9 different pharma companies huddled together with massive overlapping business functions which wastes away the little profits we make.
What the new CEO should have done was cut out the wasteful overlap and trim down or layoff the 130+ Vice President positions, especially as most of these VPs are pure dead weight (especially on the R&D side).
Roger Daltrey from The Who said it best..."meet the new boss, same as the old boss!"
Takeda has more than DOUBLED in size in the last 4 years and has nothing to show on the bottom line for all this growth. The company desperately needs strong leadership at the top and all we got so far from the Frenchie is a good signal that he has no backbone to make significant and painful changes that this company so desperately needs.
There is no "one Takeda", the corporation operates as 8 or 9 different pharma companies huddled together with massive overlapping business functions which wastes away the little profits we make.
What the new CEO should have done was cut out the wasteful overlap and trim down or layoff the 130+ Vice President positions, especially as most of these VPs are pure dead weight (especially on the R&D side).
Roger Daltrey from The Who said it best..."meet the new boss, same as the old boss!"
French CEO Did Nothing
Aucun commentaire:
Enregistrer un commentaire